A randomized controlled trial found that Mylovia, a self-guided digital app combining cognitive behavioral therapy (CBT) and mindfulness techniques, significantly improved sexual functioning in women with sexual dysfunction. Among 252 women who used the app alongside standard care, those in the intervention group showed meaningful improvements in sexual desire, satisfaction, and pain-related thoughts and behaviors compared to those receiving standard care alone. Why Is Female Sexual Dysfunction So Often Left Untreated? Sexual dysfunction affects a staggering number of women, yet remains one of medicine's most overlooked health issues. According to research cited in the study, nearly half of sexually active women in Germany experienced at least one sexual problem within the past 12 months, and 17.5% met clinical criteria for conditions like low sexual desire, arousal difficulties, orgasmic dysfunction, or sexual pain. Despite this prevalence, the vast majority go untreated. In one German primary care sample, 84.8% of women with clinically relevant sexual dysfunction described themselves as untreated. The reasons for this treatment gap are deeply rooted in systemic issues. Female sexuality still carries significant stigma and shame in clinical settings, making it largely absent from conversations between patients and doctors. Physicians typically receive little formal training on sexuality and often either focus narrowly on isolated symptoms or refer patients to psychotherapists who may lack adequate expertise themselves. This represents what researchers call a gender healthcare inequity, since male sexual dysfunctions have been far more extensively researched and addressed in medicine. What Makes This Digital Therapy Different From Traditional Treatment? The Mylovia app takes a comprehensive, modern approach to female sexual health that moves beyond outdated, narrow frameworks. Rather than focusing solely on reproduction or enabling penetration, the app emphasizes desire, pleasure, and personal agency. It combines evidence-based components including psychoeducation, body awareness exercises, mindfulness practices, self-exploration techniques, and communication skills training. In the randomized controlled trial, women using Mylovia alongside standard care showed significantly greater improvements in sexual functioning compared to those receiving standard care plus information materials alone. The improvement was measured using the Female Sexual Function Index (FSFI), a validated assessment tool, and the benefits persisted at the six-month follow-up. The effect size was substantial enough to be clinically meaningful, not just statistically significant. What sets digital interventions apart is their accessibility and discretion. Unlike traditional therapy, which requires scheduling appointments and discussing intimate concerns face-to-face with a provider, digital apps can be used privately at home on your own schedule. This addresses major barriers to treatment, including stigma, lack of time, and limited access to specialists with expertise in sexual health. How to Access Evidence-Based Sexual Health Support - Explore Digital Therapeutics: In countries like Germany, digital therapeutics vetted by regulatory bodies can be prescribed by physicians and psychotherapists, similar to medication, and may be covered by health insurance. Ask your doctor whether a digital therapeutic option is available for your specific concerns. - Seek Providers With Sexual Health Training: Look for therapists or physicians who specialize in sexual health or have formal training in sex therapy. Organizations like the International Consultation on Sexual Medicine (ICSM) and the International Society for the Study of Women's Sexual Health (ISSWSH) can help you find qualified providers. - Understand the Biopsychosocial Approach: Effective sexual health treatment addresses physical, psychological, and relational factors. Ensure any provider or program you consider takes this comprehensive view rather than focusing narrowly on one aspect of sexuality. - Prioritize Pleasure and Agency: Modern evidence-based approaches emphasize your desire, satisfaction, and personal agency, not just medical definitions of dysfunction. Any treatment should center your own goals and values. What Do the Study Results Actually Show? The trial involved 252 women with sexual dysfunction who were randomly assigned to receive either standard care plus the Mylovia app or standard care plus general information materials. At three months, the Mylovia group showed significantly greater improvements in sexual functioning, with an effect size of 0.51, which is comparable to the effectiveness of traditional psychosocial treatments documented in prior research. Women in the app group also reported greater improvements in sexual desire, sexual satisfaction, and pain-related cognitions and behaviors. Importantly, there were no significant differences between groups in depressive symptoms or adverse events, indicating the app was safe. The fact that digital interventions can match the effectiveness of in-person therapy is particularly significant given the current shortage of sexual health specialists. This suggests that apps like Mylovia could help narrow the gender healthcare gap by making evidence-based treatment available to far more women than traditional therapy alone could reach. Why Does Sexual Health Matter Beyond the Bedroom? Sexual dysfunction is not simply a quality-of-life issue, though that alone would be important. Research shows that sexual problems significantly impact multiple domains of wellbeing, including overall quality of life, self-esteem, body image, and relationship satisfaction. When women lack support for their sexual health concerns, these ripple effects can affect mental health, intimate relationships, and overall sense of agency and self-worth. The World Health Organization recognizes sexual health as fundamental to overall health and wellbeing, as well as to social and economic development. Yet despite this recognition, female sexual health has been consistently under-researched, undervalued, and overlooked in clinical practice compared to male sexual health. Digital therapeutics like Mylovia represent a step toward correcting this long-standing inequity by making evidence-based support more accessible and less stigmatized.
